MSLN and ovarian carcinoma: ROC curve analysis resulted in AUCs of 0.80 (p<0.0001) for FRA and MSLN (p<0.0001) and 0.641 (p=0.0007) for MPF (Figure 3) suggesting that FRA and MSLN have greater potential with respect to discrimination of individuals with ovarian cancer compared to normal individuals, independent of other clinical variables.